LT Keith Warshany, Pharm.D., is Staff Pharmacist, Northern Navajo Medical Center, Indian Health Service, Shiprock, NM; when the project described in this article was undertaken, he was doctor of pharmacy candidate, University of North Carolina (UNC) Eshelman School of Pharmacy, UNC at Chapel Hill, Chapel Hill. Christina H. Sherrill, Pharm.D., is Postgraduate Year 1 Pharmacy Resident, Charles George Veterans Affairs Medical Center, Asheville, NC; when the project described was undertaken, she was doctor of pharmacy candidate, UNC Eshelman School of Pharmacy, UNC at Chapel Hill. Jamie Cavanaugh, Pharm.D., BCPS, CPP, is Clinical Assistant Professor, UNC School of Medicine, and Assistant Professor of Clinical Education, UNC Eshelman School of Pharmacy; Timothy J. Ives, Pharm.D., M.P.H., BCPS, FCCP, CPP, is Professor, UNC Eshelman School of Pharmacy, and Adjunct Professor, UNC School of Medicine; and Betsy Bryant Shilliday, Pharm.D., CDE, CPP, BCACP, is Associate Professor of Clinical Education, UNC Eshelman School of Pharmacy, and Clinical Associate Professor, UNC School of Medicine, UNC at Chapel Hill.
Am J Health Syst Pharm. 2014 Jan 1;71(1):44-9. doi: 10.2146/ajhp130202.
The clinical and financial outcomes of an initial Medicare annual wellness visit (AWV) administered by a clinical pharmacist practitioner (CPP) in an academic internal medicine clinic are described.
As a result of the Patient Protection and Affordable Care Act, Medicare Part B allows for coverage of an AWV at no cost to eligible beneficiaries. The AWV is directed at health prevention, disease detection, and coordination of screening available to beneficiaries. CPPs are pharmacists who are recognized as advanced practice providers in the state of North Carolina and are authorized to administer AWVs. Eligible Medicare beneficiaries at least 65 years of age in an academic internal medicine clinic were mailed invitations to schedule an AWV. Patients who scheduled an AWV were mailed a packet to complete before the visit. During the visit, the packet was reviewed and interventions were made based on prespecified criteria derived from evidence-based medicine recommendations. After completion of the AWV, patients were provided with a detailed and individualized prevention plan. Between August 2011 and May 2012, 98 patients attended an AWV, all performed by the same CPP. The average time from check in to checkout for all patients was 73 minutes. The CPP made 441 interventions during these 98 visits, averaging 4.5 interventions per AWV completed. All initial AWVs were reimbursable up to a maximum of $159.38 per visit.
A Medicare AMV administered by a CPP resulted in a wide variety of patient interventions and reimbursement for services provided.
描述临床药师从业者(CPP)在学术内科诊所进行的初始 Medicare 年度健康访视(AWV)的临床和财务结果。
根据《患者保护与平价医疗法案》,Medicare Part B 允许为符合条件的受益人免费提供 AWV。AWV 旨在针对健康预防、疾病检测以及向受益人提供的筛查进行协调。CPP 是在北卡罗来纳州被认可为高级实践提供者的药剂师,有权进行 AWV。学术内科诊所中至少 65 岁的合格 Medicare 受益人收到了预约 AWV 的邀请函。预约 AWV 的患者会收到一份在访问前填写的包裹。在访问期间,根据基于循证医学建议的既定标准审查包裹并进行干预。AWV 完成后,为患者提供详细和个性化的预防计划。2011 年 8 月至 2012 年 5 月期间,98 名患者参加了 AWV,均由同一位 CPP 进行。所有患者的平均登记到结账时间为 73 分钟。CPP 在这 98 次访问中进行了 441 次干预,平均每次 AWV 完成 4.5 次干预。所有初始 AWV 的报销上限为每次访问最高 159.38 美元。
由 CPP 管理的 Medicare AMV 导致了各种患者干预措施和提供服务的报销。